LEF1 and breast cancer: To find the relevance of the NUMB, TCF7, and LEF1 promoters to β-catenin/RAC1, we performed a ChIP assay using anti-β-catenin/anti-RAC1 antibody in both colon and breast cancer chromatin samples.